Viewing Study NCT06249867


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-30 @ 2:23 PM
Study NCT ID: NCT06249867
Status: RECRUITING
Last Update Posted: 2025-09-05
First Post: 2024-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
Sponsor: Oliver Blanchard
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module